103 related articles for article (PubMed ID: 9452221)
1. Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamide.
Penkowa M; Hidalgo J; Moos T
Brain Res; 1997 Nov; 774(1-2):256-9. PubMed ID: 9452221
[TBL] [Abstract][Full Text] [Related]
2. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Hidalgo J
Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
4. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J
Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
6. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Poulsen C; Carrasco J; Hidalgo J
Exp Neurol; 2002 Aug; 176(2):308-21. PubMed ID: 12359172
[TBL] [Abstract][Full Text] [Related]
7. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of blood--tissue barrier--supporting features by hepatic stellate cells and astrocytes of myofibroblastic phenotype. Inverse dynamics of metallothionein and glial fibrillary acidic protein expression.
Buniatian GH; Hartmann HJ; Traub P; Weser U; Wiesinger H; Gebhardt R
Neurochem Int; 2001 Apr; 38(5):373-83. PubMed ID: 11222917
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
10. Glial immunoreactivity for metallothionein in the rat brain.
Young JK; Garvey JS; Huang PC
Glia; 1991; 4(6):602-10. PubMed ID: 1720764
[TBL] [Abstract][Full Text] [Related]
11. Distribution of metallothionein I + II and vesicular zinc in the developing central nervous system: correlative study in the rat.
Penkowa M; Nielsen H; Hidalgo J; Bernth N; Moos T
J Comp Neurol; 1999 Sep; 412(2):303-18. PubMed ID: 10441758
[TBL] [Abstract][Full Text] [Related]
12. Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes.
Buniatian GH; Hartmann HJ; Traub P; Wiesinger H; Albinus M; Nagel W; Shoeman R; Mecke D; Weser U
Anat Rec; 2002 Aug; 267(4):296-306. PubMed ID: 12124908
[TBL] [Abstract][Full Text] [Related]
13. Temporal relationship between aquaporin-4 and glial fibrillary acidic protein in cerebellum of neonate and adult rats administered a BBB disrupting spider venom.
Stavale LM; Soares ES; Mendonça MC; Irazusta SP; da Cruz Höfling MA
Toxicon; 2013 May; 66():37-46. PubMed ID: 23419593
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats.
Martínez-Contreras A; Huerta M; Lopez-Perez S; García-Estrada J; Luquín S; Beas Zárate C
J Neurosci Res; 2002 Jan; 67(2):200-10. PubMed ID: 11782964
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Giralt M; Camats J; Hidalgo J
J Comp Neurol; 2002 Mar; 444(2):174-89. PubMed ID: 11835189
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes.
Penkowa M; Moos T
Glia; 1995 Mar; 13(3):217-27. PubMed ID: 7782107
[TBL] [Abstract][Full Text] [Related]
17. [Blood-brain barrier breakdown following gliotoxic drug injection in the brainstem of Wistar rats].
Bondan EF; Lallo MA; Dagli ML; Pereira LA; Graca DL
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):582-9. PubMed ID: 12244396
[TBL] [Abstract][Full Text] [Related]
18. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.
Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J
Glia; 1999 Feb; 25(4):343-57. PubMed ID: 10028917
[TBL] [Abstract][Full Text] [Related]
19. Experimental gliopathy in the adult rat CNS: effect on the blood-spinal cord barrier.
Krum JM
Glia; 1994 Aug; 11(4):354-66. PubMed ID: 7960038
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening.
da Cruz-Höfling MA; Rapôso C; Verinaud L; Zago GM
Neurotoxicology; 2009 Jul; 30(4):636-46. PubMed ID: 19393263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
